2026 Global: Adaptive Servo-Ventilators (Asv) Market -Competitive Review (2032) report
Description
The 2026 Global: Adaptive Servo-Ventilators (Asv) Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for adaptive servo-ventilators (asv) market by geography and historical trend. The scope of the report extends to sizing of the adaptive servo-ventilators (asv) market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
ResMed, Philips Respironics, Fisher & Paykel Healthcare, Medtronic, Hamilton Medical, Dräger, Getinge, Vyaire Medical, Löwenstein Medical, and Teijin Pharma are among the ten major companies shaping the Adaptive Servo-Ventilators (ASV) market, each bringing distinct strengths in device design, clinical evidence, and distribution networks. ResMed is a leader in home sleep therapy with the AirCurve 10 ASV platform that combines adaptive algorithms and cloud connectivity for remote monitoring and therapy optimization. Philips Respironics, historically prominent in sleep and respiratory care, offers ASV-capable platforms and has invested in research to refine safety and effectiveness for complex sleep-disordered breathing. Fisher & Paykel Healthcare focuses on patient comfort and humidification in non-invasive ventilation, leveraging strong expertise in interface design and home-care adoption to expand ASV access. Medtronic and Hamilton Medical are recognized for critical-care ventilators that incorporate advanced ventilation modes and ICU-focused ASV or adaptive modes, supporting hospitals with integrated monitoring and clinician workflow features.
Dräger and Getinge concentrate on high-reliability ICU ventilators and integrated critical-care solutions, emphasizing robustness, modularity, and hospital-system integration that accommodate ASV capabilities in acute settings. Vyaire Medical and Löwenstein Medical serve specialty niches within respiratory and sleep therapy markets; Vyaire’s focus on ventilation consumables and platforms supports broader clinical deployment while Löwenstein provides ASV and titration devices tailored to sleep-lab and home titration workflows. Teijin Pharma, active in respiratory and related therapeutic domains, contributes through product portfolios and partnerships that help bridge pharmacologic and device-based management of respiratory conditions, complementing ASV adoption in specified patient groups. Across these firms there is a mix of strategies—consumer-facing home devices with digital health integration, hospital-grade ventilators with multi-parameter monitoring, and accessory/interface innovation—that together expand ASV use from specialized sleep centers into broader pulmonary and critical-care practice.
Market dynamics among these ten companies reflect competing priorities: improving patient synchrony and comfort, enhancing safety in complex central sleep apnea, meeting regulatory scrutiny, and scaling distribution into emerging regions. ResMed and Philips emphasize algorithm refinement and remote management for ambulatory patients while Hamilton, Dräger, and Getinge prioritize ICU performance, durability, and interoperability with hospital information systems. Fisher & Paykel and Löwenstein invest in mask interfaces, humidification, and titration tools to increase adherence and therapy tolerance. Medtronic, Vyaire, and Teijin strengthen market coverage via broad ventilator portfolios, service networks, and collaborations that address training and clinical adoption barriers; collectively these companies drive innovation, evidence generation, and geographic expansion that shape ASV availability across home, sleep-lab, and acute-care settings.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for adaptive servo-ventilators (asv) market by geography and historical trend. The scope of the report extends to sizing of the adaptive servo-ventilators (asv) market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
ResMed, Philips Respironics, Fisher & Paykel Healthcare, Medtronic, Hamilton Medical, Dräger, Getinge, Vyaire Medical, Löwenstein Medical, and Teijin Pharma are among the ten major companies shaping the Adaptive Servo-Ventilators (ASV) market, each bringing distinct strengths in device design, clinical evidence, and distribution networks. ResMed is a leader in home sleep therapy with the AirCurve 10 ASV platform that combines adaptive algorithms and cloud connectivity for remote monitoring and therapy optimization. Philips Respironics, historically prominent in sleep and respiratory care, offers ASV-capable platforms and has invested in research to refine safety and effectiveness for complex sleep-disordered breathing. Fisher & Paykel Healthcare focuses on patient comfort and humidification in non-invasive ventilation, leveraging strong expertise in interface design and home-care adoption to expand ASV access. Medtronic and Hamilton Medical are recognized for critical-care ventilators that incorporate advanced ventilation modes and ICU-focused ASV or adaptive modes, supporting hospitals with integrated monitoring and clinician workflow features.
Dräger and Getinge concentrate on high-reliability ICU ventilators and integrated critical-care solutions, emphasizing robustness, modularity, and hospital-system integration that accommodate ASV capabilities in acute settings. Vyaire Medical and Löwenstein Medical serve specialty niches within respiratory and sleep therapy markets; Vyaire’s focus on ventilation consumables and platforms supports broader clinical deployment while Löwenstein provides ASV and titration devices tailored to sleep-lab and home titration workflows. Teijin Pharma, active in respiratory and related therapeutic domains, contributes through product portfolios and partnerships that help bridge pharmacologic and device-based management of respiratory conditions, complementing ASV adoption in specified patient groups. Across these firms there is a mix of strategies—consumer-facing home devices with digital health integration, hospital-grade ventilators with multi-parameter monitoring, and accessory/interface innovation—that together expand ASV use from specialized sleep centers into broader pulmonary and critical-care practice.
Market dynamics among these ten companies reflect competing priorities: improving patient synchrony and comfort, enhancing safety in complex central sleep apnea, meeting regulatory scrutiny, and scaling distribution into emerging regions. ResMed and Philips emphasize algorithm refinement and remote management for ambulatory patients while Hamilton, Dräger, and Getinge prioritize ICU performance, durability, and interoperability with hospital information systems. Fisher & Paykel and Löwenstein invest in mask interfaces, humidification, and titration tools to increase adherence and therapy tolerance. Medtronic, Vyaire, and Teijin strengthen market coverage via broad ventilator portfolios, service networks, and collaborations that address training and clinical adoption barriers; collectively these companies drive innovation, evidence generation, and geographic expansion that shape ASV availability across home, sleep-lab, and acute-care settings.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
